Product Information
LEVALBUTEROL 0.31 MG/3 ML SOL is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.3455 per ML under NDC 00093414556. Its NADAC has been published 336 times since Dec 18, 2019.
FDA first approved this application on Apr 26, 2013. Its Orange Book therapeutic-equivalence code is AN.
Strength
.31 mg/3mL
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093414556
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
8/19/2026
Active Ingredients
LEVALBUTEROL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090297FDA Approved
4/26/2013
TE Code
AN
On Market Since
4/29/2013
Pharmacological Classes
Price Statistics
The NADAC for LEVALBUTEROL 0.31 MG/3 ML SOL has been published 336 times since Dec 18, 2019, and over the history we have for it it has declined 24.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3455 per ML |
|---|---|
| All-time high | $0.4560 (Dec 16, 2020) |
| All-time low | $0.2699 (Feb 19, 2025) |
| 52-week high | $0.4326 |
| 52-week low | $0.3001 |
| Median price | $0.3373 |
| Average price | $0.3716 |
| Largest weekly change | -24.5% (Feb 23, 2022) |
| Weeks tracked | 336 |
| Tracking since | Dec 18, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LEVALBUTEROL 0.31 MG/3 ML SOL?
The current National Average Drug Acquisition Cost (NADAC) for LEVALBUTEROL 0.31 MG/3 ML SOL, manufactured by Teva Pharmaceuticals USA Inc., is $0.3455 per ML (NDC 00093414556), effective Aug 19, 2026.
How has the price of LEVALBUTEROL 0.31 MG/3 ML SOL changed over time?
Over the history we have for it, the NADAC for LEVALBUTEROL 0.31 MG/3 ML SOL has declined 24.2%. It has been tracked across 336 weekly CMS publications since Dec 18, 2019.
What are the highest and lowest recorded NADAC prices for LEVALBUTEROL 0.31 MG/3 ML SOL?
Since Dec 18, 2019, the NADAC for LEVALBUTEROL 0.31 MG/3 ML SOL has ranged from a low of $0.2699 (Feb 19, 2025) to a high of $0.4560 (Dec 16, 2020), with a median of $0.3373 per ML.
Are there cheaper alternatives to LEVALBUTEROL 0.31 MG/3 ML SOL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVALBUTEROL 0.31 MG/3 ML SOL, is $0.2661 per ML — about 23% below LEVALBUTEROL 0.31 MG/3 ML SOL.
Who manufactures LEVALBUTEROL 0.31 MG/3 ML SOL?
LEVALBUTEROL 0.31 MG/3 ML SOL (NDC 00093414556) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.